Modulation of bacterial aggregation by PMN and platelet extracts

Daniel Malamud, R. Goldman, N. S. Taichman

Research output: Contribution to journalArticle

Abstract

Human parotid saliva contains agglutinins which bind to the surface of streptococci and induce the formation of bacterial aggregates. Bacterial aggregation can be blocked by proteins released from viable PMNs and platelets or by sonic extracts prepared from these cells. PMN and platelet inhibitors display characteristic differences in molecular weight, protease, and temperature sensitivity. The mechanism of action of the inhibitors appears to involve a direct interaction with the salivary agglutinins rather than with the bacteria. It is thus possible that PMN and platelet-derived products might modulate saliva-mediated bacterial aggregation and thereby influence the course of infections in the oral cavity.

Original languageEnglish (US)
Pages (from-to)133-144
Number of pages12
JournalInflammation
Volume7
Issue number2
DOIs
StatePublished - Jun 1983

Fingerprint

Agglutinins
Platelet Aggregation
Saliva
Blood Platelets
Platelet Aggregation Inhibitors
Streptococcus
Cell Extracts
Mouth
Peptide Hydrolases
Molecular Weight
Bacteria
Temperature
Infection
Proteins

ASJC Scopus subject areas

  • Medicine(all)
  • Immunology
  • Cell Biology

Cite this

Modulation of bacterial aggregation by PMN and platelet extracts. / Malamud, Daniel; Goldman, R.; Taichman, N. S.

In: Inflammation, Vol. 7, No. 2, 06.1983, p. 133-144.

Research output: Contribution to journalArticle

Malamud, Daniel ; Goldman, R. ; Taichman, N. S. / Modulation of bacterial aggregation by PMN and platelet extracts. In: Inflammation. 1983 ; Vol. 7, No. 2. pp. 133-144.
@article{352027f22ce64e52bb05dd80545d5d2b,
title = "Modulation of bacterial aggregation by PMN and platelet extracts",
abstract = "Human parotid saliva contains agglutinins which bind to the surface of streptococci and induce the formation of bacterial aggregates. Bacterial aggregation can be blocked by proteins released from viable PMNs and platelets or by sonic extracts prepared from these cells. PMN and platelet inhibitors display characteristic differences in molecular weight, protease, and temperature sensitivity. The mechanism of action of the inhibitors appears to involve a direct interaction with the salivary agglutinins rather than with the bacteria. It is thus possible that PMN and platelet-derived products might modulate saliva-mediated bacterial aggregation and thereby influence the course of infections in the oral cavity.",
author = "Daniel Malamud and R. Goldman and Taichman, {N. S.}",
year = "1983",
month = "6",
doi = "10.1007/BF00917818",
language = "English (US)",
volume = "7",
pages = "133--144",
journal = "Inflammation",
issn = "0360-3997",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Modulation of bacterial aggregation by PMN and platelet extracts

AU - Malamud, Daniel

AU - Goldman, R.

AU - Taichman, N. S.

PY - 1983/6

Y1 - 1983/6

N2 - Human parotid saliva contains agglutinins which bind to the surface of streptococci and induce the formation of bacterial aggregates. Bacterial aggregation can be blocked by proteins released from viable PMNs and platelets or by sonic extracts prepared from these cells. PMN and platelet inhibitors display characteristic differences in molecular weight, protease, and temperature sensitivity. The mechanism of action of the inhibitors appears to involve a direct interaction with the salivary agglutinins rather than with the bacteria. It is thus possible that PMN and platelet-derived products might modulate saliva-mediated bacterial aggregation and thereby influence the course of infections in the oral cavity.

AB - Human parotid saliva contains agglutinins which bind to the surface of streptococci and induce the formation of bacterial aggregates. Bacterial aggregation can be blocked by proteins released from viable PMNs and platelets or by sonic extracts prepared from these cells. PMN and platelet inhibitors display characteristic differences in molecular weight, protease, and temperature sensitivity. The mechanism of action of the inhibitors appears to involve a direct interaction with the salivary agglutinins rather than with the bacteria. It is thus possible that PMN and platelet-derived products might modulate saliva-mediated bacterial aggregation and thereby influence the course of infections in the oral cavity.

UR - http://www.scopus.com/inward/record.url?scp=0020605359&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020605359&partnerID=8YFLogxK

U2 - 10.1007/BF00917818

DO - 10.1007/BF00917818

M3 - Article

VL - 7

SP - 133

EP - 144

JO - Inflammation

JF - Inflammation

SN - 0360-3997

IS - 2

ER -